Timothy P. Reilly

3.1k total citations
35 papers, 1.9k citations indexed

About

Timothy P. Reilly is a scholar working on Pharmacology, Oncology and Immunology. According to data from OpenAlex, Timothy P. Reilly has authored 35 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 11 papers in Oncology and 9 papers in Immunology. Recurrent topics in Timothy P. Reilly's work include Drug-Induced Hepatotoxicity and Protection (11 papers), Drug-Induced Adverse Reactions (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Timothy P. Reilly is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (11 papers), Drug-Induced Adverse Reactions (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Timothy P. Reilly collaborates with scholars based in United States, Germany and China. Timothy P. Reilly's co-authors include Lance R. Pohl, Mohammed Bourdi, John W. George, Cynthia Ju, John Brady, Michael F. Radonovich, Craig K. Svensson, Yasuhiro Masubuchi, Patrick M. Woster and Cynthia A. Pise-Masison and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Hepatology.

In The Last Decade

Timothy P. Reilly

35 papers receiving 1.9k citations

Peers

Timothy P. Reilly
Mohammed Bourdi United States
Lydiane Pichard‐Garcia France
Kevin B. Park United Kingdom
Zhang‐Xu Liu United States
Lily Dara United States
Yves Horsmans Belgium
Shigeru Ohmori Japan
Ming Niu China
Kazuyoshi Kon Japan
Mikihiro Tsutsumi Japan
Mohammed Bourdi United States
Timothy P. Reilly
Citations per year, relative to Timothy P. Reilly Timothy P. Reilly (= 1×) peers Mohammed Bourdi

Countries citing papers authored by Timothy P. Reilly

Since Specialization
Citations

This map shows the geographic impact of Timothy P. Reilly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy P. Reilly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy P. Reilly more than expected).

Fields of papers citing papers by Timothy P. Reilly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy P. Reilly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy P. Reilly. The network helps show where Timothy P. Reilly may publish in the future.

Co-authorship network of co-authors of Timothy P. Reilly

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy P. Reilly. A scholar is included among the top collaborators of Timothy P. Reilly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy P. Reilly. Timothy P. Reilly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Caetano, Mauricio S., Ahmed Younes, Hampartsoum B. Barsoumian, et al.. (2019). Triple Therapy with MerTK and PD1 Inhibition Plus Radiotherapy Promotes Abscopal Antitumor Immune Responses. Clinical Cancer Research. 25(24). 7576–7584. 54 indexed citations
2.
Ptaszynska, Agata, Samuel M. Cohen, Edward M. Messing, et al.. (2015). Assessing Bladder Cancer Risk in Type 2 Diabetes Clinical Trials: the Dapagliflozin Drug Development Program as a ‘Case Study’. Diabetes Therapy. 6(3). 357–375. 55 indexed citations
3.
You, Qiang, Wang Hong, Becky A. de la Houssaye, et al.. (2014). Mice Lacking Natural Killer T Cells Are More Susceptible to Metabolic Alterations following High Fat Diet Feeding. PLoS ONE. 9(1). e80949–e80949. 55 indexed citations
4.
Reilly, Timothy P., Michael J. Graziano, Evan B. Janovitz, et al.. (2014). Carcinogenicity Risk Assessment Supports the Chronic Safety of Dapagliflozin, an Inhibitor of Sodium–Glucose Co-Transporter 2, in the Treatment of Type 2 Diabetes Mellitus. Diabetes Therapy. 5(1). 73–96. 55 indexed citations
5.
Fletcher, Anthony M., Susan Bonner‐Weir, Raja S. Mangipudy, et al.. (2013). Occurrence of Spontaneous Pancreatic Lesions in Normal and Diabetic Rats: A Potential Confounding Factor in the Nonclinical Assessment of GLP-1–Based Therapies. Diabetes. 63(4). 1303–1314. 29 indexed citations
6.
Jabbour, Serge, Jean M. Whaley, Mark A. Tirmenstein, et al.. (2012). Targeting Renal Glucose Reabsorption for the Treatment of Type 2 Diabetes Mellitus Using the SGLT2 Inhibitor Dapagliflozin. Postgraduate Medicine. 124(4). 62–73. 12 indexed citations
7.
Herbst, John J., et al.. (2011). Evaluation and validation of multiple cell lines and primary mouse macrophages to predict phospholipidosis potential. Toxicology in Vitro. 25(8). 1934–1943. 14 indexed citations
8.
Luyendyk, James P., Lois D. Lehman‐McKeeman, David M. Nelson, et al.. (2006). Unique Gene Expression and Hepatocellular Injury in the Lipopolysaccharide-Ranitidine Drug Idiosyncrasy Rat Model: Comparison with Famotidine. Toxicological Sciences. 90(2). 569–585. 9 indexed citations
9.
Luyendyk, James P., Lois D. Lehman‐McKeeman, David M. Nelson, et al.. (2006). Coagulation-Dependent Gene Expression and Liver Injury in Rats Given Lipopolysaccharide with Ranitidine but Not with Famotidine. Journal of Pharmacology and Experimental Therapeutics. 317(2). 635–643. 20 indexed citations
10.
You, Qiang, Linling Cheng, Timothy P. Reilly, Dale R. Wegmann, & Cynthia Ju. (2006). Role of neutrophils in a mouse model of halothane-induced liver injury. Hepatology. 44(6). 1421–1431. 89 indexed citations
11.
Roychowdhury, Sanjoy, et al.. (2005). Characterization of the Formation and Localization of Sulfamethoxazole and Dapsone-Associated Drug-Protein Adducts in Human Epidermal Keratinocytes. Journal of Pharmacology and Experimental Therapeutics. 314(1). 43–52. 47 indexed citations
12.
Welch, Kevin D., Bo Wen, David R. Goodlett, et al.. (2005). Proteomic Identification of Potential Susceptibility Factors in Drug-Induced Liver Disease. Chemical Research in Toxicology. 18(6). 924–933. 53 indexed citations
13.
Masubuchi, Yasuhiro, Mohammed Bourdi, Timothy P. Reilly, et al.. (2003). Role of interleukin-6 in hepatic heat shock protein expression and protection against acetaminophen-induced liver disease. Biochemical and Biophysical Research Communications. 304(1). 207–212. 115 indexed citations
14.
Reilly, Timothy P. & Cynthia Ju. (2002). Mechanistic perspectives on sulfonamide-induced cutaneous drug reactions. Current Opinion in Allergy and Clinical Immunology. 2(4). 307–315. 31 indexed citations
15.
Bourdi, Mohammed, Timothy P. Reilly, Abdel G. Elkahloun, John W. George, & Lance R. Pohl. (2002). Macrophage migration inhibitory factor in drug-induced liver injury: a role in susceptibility and stress responsiveness. Biochemical and Biophysical Research Communications. 294(2). 225–230. 44 indexed citations
16.
Bourdi, Mohammed, Yasuhiro Masubuchi, Timothy P. Reilly, et al.. (2002). Protection against acetaminophen-induced liver injury and lethality by interleukin 10: Role of inducible nitric oxide synthase. Hepatology. 35(2). 289–298. 244 indexed citations
17.
Reilly, Timothy P., Mohammed Bourdi, John Brady, et al.. (2001). Expression Profiling of Acetaminophen Liver Toxicity in Mice Using Microarray Technology. Biochemical and Biophysical Research Communications. 282(1). 321–328. 87 indexed citations
18.
Reilly, Timothy P., Lawrence H. Lash, Mark A. Doll, et al.. (2000). A Role for Bioactivation and Covalent Binding within Epidermal Keratinocytes in Sulfonamide-Induced Cutaneous Drug Reactions. Journal of Investigative Dermatology. 114(6). 1164–1173. 132 indexed citations
19.
Ware, Joseph A., Timothy P. Reilly, & Craig K. Svensson. (1998). Cellular Distribution of N-Acetyltransferase Activity in the Rat Small Intestine. Biochemical Pharmacology. 55(9). 1475–1479. 3 indexed citations
20.
Reilly, Timothy P., et al.. (1998). Comparison of the In Vitro Cytotoxicity of Hydroxylamine Metabolites of Sulfamethoxazole and Dapsone. Biochemical Pharmacology. 55(6). 803–810. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mohammed Bourdi Breakdown of academic impact, for papers by Lydiane Pichard‐Garcia Breakdown of academic impact, for papers by Kevin B. Park Breakdown of academic impact, for papers by Zhang‐Xu Liu Breakdown of academic impact, for papers by Lily Dara Breakdown of academic impact, for papers by Yves Horsmans Breakdown of academic impact, for papers by Shigeru Ohmori Breakdown of academic impact, for papers by Ming Niu Breakdown of academic impact, for papers by Kazuyoshi Kon Breakdown of academic impact, for papers by Mikihiro Tsutsumi
Rankless by CCL
2026